An updated review of mesoporous carbon as a novel drug delivery system

Faculty Pharmacy Year: 2021
Type of Publication: ZU Hosted Pages: 1029-1037
Authors:
Journal: Drug Development and Industrial Pharmacy Taylor & Francis Volume: 47
Keywords : , updated review , mesoporous carbon , , novel drug    
Abstract:
The nanotechnology approach has been recently adopted to provide more reliable, effective, controlled, and safe drug delivery systems. Nanostructured materials have gained great interest, including siliceous and carbonaceous nanoparticles. The effectiveness of mesoporous carbon nanoparticles (MCNs) in tumor imaging, targeting, and treatment is urging for more future studies. MCNs possess superior properties such as their biocompatibility, large surface area, large pore volume, tunability, and more responsive behavior to internal and external release triggers. These outstanding features make MCNs more applicable for stimuli-responsive drug delivery than the conventional forms of mesoporous silica nanoparticles (MSNs) and other carbon nanoparticles. In this review, we outlined the latest updates regarding the safety, benefits, and potential applications of MCNs.
   
     
 
       

Author Related Publications

    Department Related Publications

    • Azza Ali Hassan Solyman, "formulation and optimization of olanzapine-carboxylic acid cocrystals orodispersible tablets: in-vitro/in-vivo study", Elsevier, 2024 More
    • Hanaa Abdelfattah Attia Elghamry, "formulation and optimization of olanzapine-carboxylic acid cocrystals orodispersible tablets: in-vitro/in-vivo study", Elsevier, 2024 More
    • Gehan Fathy Attia Elsayed Balata, "formulation and optimization of olanzapine-carboxylic acid cocrystals orodispersible tablets: in-vitro/in-vivo study", Elsevier, 2024 More
    • Sherif Emam Abdallah Emam, "Rutin-loaded fast-dissolving sublingual niosomal film: Design, characterization, hepatoprotective potential, and pharmacokinetic evaluation in ceftriaxone-induced liver injury in rats", Elsevier, 2025 More
    Tweet